Newborn RSV antibodies could avert 61% of early-infant admissions, ECDC finds
Ten models across 28 EU/EEA countries project that universal newborn RSV antibodies at 90% coverage would prevent 61% of hospital admissions in the first two months of life; maternal vaccination 52%.